Literature DB >> 12731673

Cytotoxic T-cell lymphoma arising in Behçet disease.

Yukitaka Katsura1, Kazumi Suzukawa, Hiroshi Kojima, Chikashi Yoshida, Seiichi Shimizu, Harumi Mukai, Yuichi Hasegawa, Shigehiko Imagawa, Naoyoshi Mori, Toshiro Nagasawa.   

Abstract

The case of a 49-year-old man with peripheral T-cell lymphoma arising in Behcet disease (BD) is reported. A diagnosis of incomplete BD was made, and the patient was treated with immunosuppressive agents for 9 months. A left perirenal mass emerged, and a computed tomography-guided needle biopsy of the tumor revealed the infiltration of small- and medium-sized lymphoma cells. The cells were positive for CD3, CD8, CD45RO, CD43, granzyme B, and T-cell intracellular antigen-1. A diagnosis of non-Hodgkin's lymphoma (diffuse medium, T-cell) was made. A left orbital mass also appeared. Standard combination chemotherapy diminished the perirenal and orbital lesions. Lymphoma cell infiltration in the esophagus was detected after chemotherapy, and the patient died of massive bleeding from the gastrointestinal tract. Non-Hodgkin's lymphoma is rarely associated with BD, and only 7 cases have been reported in the literature. We have summarized the published case reports of malignant lymphoma arising in BD. To our knowledge, this case report is the first to describe cytotoxic T-cell lymphoma arising in Behçet disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12731673     DOI: 10.1007/bf02983787

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  25 in total

Review 1.  Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.

Authors:  H Direskeneli
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 2.  Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.

Authors:  P Kanavaros; M L Boulland; B Petit; B Arnulf; P Gaulard
Journal:  Leuk Lymphoma       Date:  2000-07

3.  [Angiocentric lymphoma in Behçet's disease].

Authors:  I Moulonguet-Michau; F Blanc; B Cavelier-Balloy; P Brice; B Flageul; J Civatte
Journal:  Ann Dermatol Venereol       Date:  1990       Impact factor: 0.777

Review 4.  Extranodal peripheral T-cell and NK-cell neoplasms.

Authors:  E S Jaffe; L Krenacs; S Kumar; D W Kingma; M Raffeld
Journal:  Am J Clin Pathol       Date:  1999-01       Impact factor: 2.493

Review 5.  Recent research into Behçet's disease in Japan.

Authors:  Y Mizushima
Journal:  Int J Tissue React       Date:  1988

Review 6.  Spontaneously relapsing clonal, mucosal cytotoxic T-cell lymphoproliferative disorder: case report and review of the literature.

Authors:  E A Ranheim; C Jones; J L Zehnder; R Warnke; A Yuen
Journal:  Am J Surg Pathol       Date:  2000-02       Impact factor: 6.394

7.  Malignancy in a series of 70 patients with systemic lupus erythematosus.

Authors:  J J Canoso; A S Cohen
Journal:  Arthritis Rheum       Date:  1974 Jul-Aug

8.  Intestinal Behçet's disease associated with non-Hodgkin's lymphoma.

Authors:  T Yamamoto; M Tamura; T Hamauzu; A Nakayama; K Kawasugi; M Kamakura; T Kinoshita; Y Kuyama; M Yamanaka; L M Wang; M Sanaka; S Mineshita
Journal:  J Gastroenterol       Date:  1997-04       Impact factor: 7.527

Review 9.  [Intracranial primary malignant lymphoma following Behçet's disease--case report].

Authors:  K Harada; K Ohtsuru; K Nakayama; S Takagi; Y Sugita; R Torigoe
Journal:  No To Shinkei       Date:  1992-11

Review 10.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

View more
  1 in total

1.  One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs.

Authors:  Annarita Giardina; Angelo Ferrante; Francesco Ciccia; Maria Vadalà; Ennio Giardina; Giovanni Triolo
Journal:  Rheumatol Int       Date:  2009-10-27       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.